Differential inductive and suppressive effects of endotoxin and particulate irritants on hepatic and renal cytochrome P-450 expression

Journal of Pharmacology and Experimental Therapeutics

Volumn 280, Issue 3, 1997, Pages 1445-1454

  Sewer, Marion B ^a   Koop, Dennis R ^b   Morgan, Edward T ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BARIUM SULFATE; CHLORZOXAZONE; CYTOCHROME P450 ISOENZYME; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; FIBRINOGEN; INFUSORIAL EARTH; IRRITANT AGENT; KAOLIN; KIDNEY ENZYME; LAURIC ACID; LIVER ENZYME; MESSENGER RNA; NITRIC OXIDE SYNTHASE; OXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME REPRESSION; INFECTION; INFLAMMATION; KIDNEY MICROSOME; LIVER MICROSOME; MALE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STRAIN DIFFERENCE;

ANIMALS; BARIUM SULFATE; BLOTTING, NORTHERN; CATALYSIS; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INDUCTION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; IRRITANTS; ISOENZYMES; KIDNEY; LIPOPOLYSACCHARIDES; LIVER; MALE; RATS; RATS, INBRED F344; RNA, MESSENGER; SILICON DIOXIDE;

EID: 0030986165     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. ARRHENIUS, E. AND HUTLIN, T.: Effects of carcinogenic amines on amino acid incorporation by liver systems. I. Secondary increase in microsomal activity after aminofluorene treatment. Cancer Res. 22: 823-834, 1962.
2. BABANY, G., DESCATOIRE, V., CORBIC, M., GENDRE, S., DEGOTT, C., LARREY, D., LETTERON, P., WANDSCHEER, J.-C., BRENTANO, C. F. AND PESSAYRE, D.: Regulation of renal cytochrome P-450: Effects of two-thirds hepatectomy, cholestasis, biliary cirrhosis and post-necrotic cirrhosis on hepatic and renal microsomal enzymes. Biochem. Pharmacol. 34: 311-320, 1985.
3. BARBU, V. AND DANTRY, F.: Northern blot normalization with a 28S rRNA probe. Nucleic Acids Res. 17: 7115, 1989.
4. BARKER, C. W., FAGAN, J. B. AND PASCO, D. S.: Interleukin-1β suppresses the induction of P4501A1 and P4501A2 mRNAs in isolated hepatocytes. J. Biol. Chem. 267: 8050-8055, 1992.
5. BAUMANN, H. AND GAULDIE, J.: Regulation of hepatic acute phase protein genes by hepatocyte stimulating factors and other mediators of inflammation. Mol. Biol. Med. 7: 147-159, 1990.
6. BECK, F. J. AND WHITEHOUSE, M. W.: Impaired drug metabolism in rats associated with acute inflammation: A possible assay for anti-injury agents. Proc. Soc. Exp. Biol. Med. 145: 135-140, 1974.
7. BILLIAR, T. R., CURRAN, R. D., WILLIAMS, D. L. AND KISPERT, P. H.: Liver nonparenchymal cells are stimulated to provide interleukin 6 for induction of the hepatic acute-phase response in endotoxemia but not in remote inflammation. Arch. Surg. 127: 31-37, 1992.
8. BIRCH, H. E. AND SCHREIBER, G.: Transcriptional regulation of plasma protein synthesis during inflammation. J. Biol. Chem. 261: 8077-8080, 1986.
9. CARLSON, T. J. AND BILLINGS, R. E.: Role of nitric oxide in the cytokine-mediated regulation of cytochrome P-450. Mol. Pharmacol. 49: 796-801, 1996.
10. CHEN, J.-Q., STRÖM, A., GUSTAFSSON, J.-A. AND MORGAN, E. T.: Suppression of the constitutive expression of cytochrome P-450 2C11 by cytokines and interferons in primary cultures of rat hepatocytes: Comparison with induction of acute-phase genes and demonstration that CYP2C11 promoter sequences are involved in the suppressive response to interleukins 1 and 6. Mol. Pharmacol. 47: 940-947, 1995.
11. CHEN, Y. L., FLORENTIN, I., BATT, A. M., FERRARI, L., GIROUD, J. P. AND CHAUVELOT-MOACHON, L.: Effects of interleukin-6 on cytochrome P450-dependent mixed function oxidases in the rat. Biochem. Pharmacol. 44: 137-148, 1992.
12. CHOMCZYNSKI, P. AND SACCHI, N.: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159, 1987.
13. CURRAN, R. D., BILLIAR, T. R., STUEHR, D. J., OCHOA, J. B., HARBRECHT, B. G., FLINT, S. G. AND SIMMONS, R. L.: Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein synthesis. Ann. Surg. 212: 462-469, 1990.
14. ENDOU, H.: Distribution and some characteristics of cytochrome P450 in the kidney. J. Toxicol. Sci. 8: 165-179, 1983.
15. ESCALANTE, B., OMATA, K., SESSA, W., LEE, S.-G., FALCK, J. R. AND SCHWARTZMAN, M. L.: 20-Hydroxyeicosatetraenoic acid is an endothelium-dependent vasoconstrictor in rabbit arteries. Eur. J. Pharmacol. 235: 1-7, 1993.
16. 2 is a ligand for the adipocyte determination factor PPARγ. Cell 83: 803-812, 1995.
17. GELLER, R. D., FREESWICK, P. D., NGUYEN, D., NUSSLER, A. K., DISILVIO, M., SHAPIRO, R. A., WANG, S. C., SIMMONS, R. L. AND BILLIAR, T. R.: Differential induction of nitric oxide synthase in hepatocytes during endotoxemia and the acute-phase response. Arch. Surg. 129: 165-171, 1994.
18. GONZALEZ, F. J., SONG, B. J. AND HARDWICK, J. P.: Pregnenolone 16 alpha-carbonitrile-inducible P-450 gene family: Gene conversion and differential regulation. Mol. Cell Biol. 6: 2969-2976, 1986.
19. GORODISCHER, R., LARSNER, J., MCDEVITT, J. J., NOLAN, J. P. AND YAFFE, S. J.: Hepatic microsomal drug metabolism after administration of endotoxin in rats. Biochem. Pharmacol. 25: 351-353, 1976.
20. HAUGEN, D. A. AND COON, M. J.: Properties of electrophoretically homogeneous phenobarbital-inducible forms of liver microsomal cytochrome P-450. J. Biol. Chem. 251: 7929-7939, 1976.
21. HODGSON, P. D. AND RENTON, K. W.: The role of nitric oxide generation in interferon-evoked cytochrome P450 down-regulation. Int. J. Immunopharmacol. 17: 995-1000, 1995.
22. HOLLANDER, M. C. AND FORNACE, A. J., JR.: Estimation of relative mRNA content by filter hybridization to a polythymidylate probe. Biotechniques 9: 174-179, 1990.
23. HOTCHKISS, J. A., KIM, H., HAHN, F. F., NOVAK, R. F. AND DAHL, A. R.: Pyridine induction of Sprague-Dawley rat renal cytochrome P4502E1: Immunohistochemical localization and quantitation. Toxicol. Lett. 78: 1-7, 1995.
24. KHATSENKO, O. G., GROSS, S. S., RIFKIND, A. B. AND VANE, J. R.: Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants. Proc. Natl. Acad. Sci. USA 90: 11147-11151, 1993.
25. KIMURA, S., HARDWICK, J. P., KOZAK, C. A. AND GONZALEZ, F. J.: The rat clofibrate-inducible CYP4A subfamily II: cDNA sequence of IVA3, mapping of the Cyp4A locus to mouse chromosome 4, and coordinate and tissue-specific regulation of the CYP4A genes. DNA 8: 517-525, 1989.
26. LAETHEM, R. M. AND KOOP, D. R.: Identification of rabbit cytochrome P450 2C1 and 2C2 as arachidonate acid epoxygenases. Mol. Pharmacol. 42: 958-963, 1992.
27. LIN, F., ABRAHAM, N. G. AND SCHWARTZMAN, M. L.: Cytochrome P450 arachidonate acid ω-hydroxylation in the proximal tubule of the rat kidney. Ann. N. Y. Acad. Scu. 774: 11-24, 1994.
28. LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L. AND RANDALL, R. J.: Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
29. MAHU, J. L. AND FELDMAN, G.: Study of biochemical behavior of some exported and nonexported hepatic proteins during an acute inflammation reaction in the rat. Enzyme 31: 234-240, 1984.
30. MAPOLES, J., BERTHOU, F., ALEXANDER, A., SIMON, F. AND MENEZ, J. F.: Mammalian PC-12 cell genetically engineered for human cytochrome-P450 2E1 expression. Eur. J. Biochem. 214: 735-745, 1993.
31. MORGAN, E. T.: Suppression of constitutive cytochrome P-450 gene expression in livers of rats undergoing an acute phase response to endotoxin. Mol. Pharmacol. 36: 699-707, 1989.
32. MORGAN, E. T.: Down regulation of multiple cytochrome P450 gene products by inflammatory mediators in vivo: Independence from the hypothalamopituitary axis. Biochem. Pharmacol. 45: 415-419, 1993.
33. MORGAN, E. T. AND NORMAN, C. A.: Pretranslational suppression of cytochrome P-450h (IIC11) gene expression in rat liver after administration of interferon inducers. Drug Metab. Dispos. 18: 649-653, 1990.
34. MORGAN, E. T., THOMAS, K. B., SWANSON, R., VALES, T., HWANG, J. AND WRIGHT, K.: Selective suppression of cytochrome P-450 gene expression by interleukins 1 and 6 in rat liver. Biochim. Biophys. Acta 1219: 475-483, 1994.
35. MUERHOFF, A. S., GRIFFIN, K. J. AND JOHNSON, E. F.: The peroxisome-proliferator-activated receptor mediates the induction of CYP4A6, a cytochrome P450 fatty acid ω-hydroxYlase, by clofibric acid. J. Biol. Chem. 267: 19051-19053, 1992.
36. MONTANE, J., LONGO, V., MITJAVILA, M. T., GERVASE, P. G. AND INGELMAN-SUNDBERG, M.: Effect of carrageenan-induced granuloma on hepatic cytochrome P-450 isozymes in rats. Inflammation 19: 143-156, 1995.
37. OKITA, J. R., CASTLE, P. J. AND OKITA, R. T.: Characterization of cytochromes P450 in liver and kidney of rats treated with di-(2-ethylhexyl)phthalate. J. Biochem. Toxicol. 8: 135-144, 1993.
38. OKITA, R. T., CLARK, J. E., OKITA, J. R. AND MASTERS, B. S. S.: Omega and (omega-1)-hydroxylation of eicosanoids and fatty acids by high-performance liquid chromatography. Methods Enzymol. 206: 432-141, 1991.
39. OMATA, K., ABRAHAM, N. G. AND LANIADO-SCHWARTZMAN, M.: Arachidonic acid ω/ω-1 hydroxylase along the nephron of the spontaneously hypertensive rat. Am. J. Physiol. 262: F595-F599, 1992.
40. OMURA, T. AND SATO, R.: The carbon-monoxide binding pigment of liver microsomes. 1. Evidence for its hemoprotein nature. J. Biol. Chem. 239: 2370-2378, 1964.
41. PETER, R., BOCKER, R., BEAUNE, P. H., IWASAKI, M., GUENGERICH, F. P. AND YANG, C. S.: Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1. Chem. Res. Toxicol. 3: 566-573, 1990. [Published erratum appears in Chem. Res. Toxicol. 4: 389, 1991.].
42. PETERSON, T. C. AND RENTON, K. W.: Kupffer cell factor mediated depression of hepatic parenchymal cell cytochrome P-450. Biochem. Pharmacol. 35: 1491-1497, 1986.
43. RENTON, K. W.: Factors affecting drug biotransformation. Clin. Biochem. 19: 72-75, 1986.
44. RENTON, K. W. AND KNICKLE, L. C.: Regulation of hepatic cytochrome P-450 during infectious disease. Can. J. Physiol. Pharmacol. 68: 777-781, 1990.
45. RICCA, G. A. AND TAYLOR, J. M.: Nucleotide sequence of rat alpha-acid glycoprotein messenger RNA. J. Biol. Chem. 256: 11199-11202, 1981.
46. ROBERTS, B. J., SHOAF, S. E., JEONG, K.-S. AND SONG, B. J.: Induction of CYP2E1 in liver, kidney, brain, and intestine during chronic ethanol administration and withdrawal: Evidence that CYP2E1 possesses a rapid phase half-life of 6 hours or less. Biochem. Biophys. Res. Commun. 205: 1064-1071, 1994.
47. SEWER, M. B., KOOP, D. R. AND MORGAN, E. T.: Endotoxemia in rats is associated with induction of the P-450 4A subfamily and suppression of several other forms of cytochrome P-450. Drug Metab. Dispos. 24: 401-407, 1996.
48. SHARMA, R. K., DOIG, M. V., LEWIS, D. F. V. AND GIBSON, G. G.: Role of hepatic and renal cytochrome P450 IVA1 in the metabolism of lipid substrates. Biochem. Pharmacol. 38: 3621-3629, 1989.
49. SOLANGI, K., SACERDOTI, D., GOODMAN, A. I., SCHWARTZMAN, M. L., ABRAHAM, N. G. AND LEVERE, R. L.: Differential effects of partial hepatectomy on hepatic and renal heme and cytochrome P450 metabolism. Am. J. Med. Sci. 296: 387-391, 1988.
50. STADLER, J., TROCKFELD, J., SCHMALIX, W. A., BRILL, T., SIEWERT, J. R., GREIN, H., AND DOEHMER, J.: Inhibition of cytochrome P4501A1 by nitric oxide. Proc. Natl. Acad. Sci. USA 91: 3559-3563, 1994.
51. STRÖM, A., MODE, A., ZAPHIROPOULOS, P., NILSSON, A.-G., MORGAN, E. AND GUSTAFSSON, J.-Å.: Cloning and pretranslational hormonal regulation of testosterone 16α-hydroxylase (P-45016α) in male rat liver. Acta Endocrinol. 118: 314-320, 1988.
52. SUNDSETH, S. S. AND WAXMAN, D. J.: Sex dependent expression and clofibrate inducibility of cytochrome P450 4A fatty acid omega hydroxylases. J. Biol. Chem. 267: 3915-3921, 1992.
53. 2 macroglobulin is a selective inhibitor of antigen-induced leukotrienes in rat isolated lungs. Br. J. Exp. Pathol. 69: 457-464, 1988.
54. WRIGHT, K. AND MORGAN, E. T.: Regulation of cytochrome P450IIC12 expression by interleukin-1α, interleukin-6, and dexamethasone. Mol. Pharmacol. 39: 468-474, 1991.
55. YAMAZAKI, H., GUO, Z. AND GUENGERICH, F. P.: Selectivity of cytochrome P4502E1 in chlorzoxazone 6-hydroxylation. Drug Metab. Dispos. 23: 438-440, 1995.
56. YU, K., BAYONA, W., KALLEN, C. B., HARDING, H. P., RAVERA, C. P., MCMAHON, G., BROWN, M. AND LAZAR, M. A.: Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J. Biol. Chem. 270: 23975-23983, 1995.
57. YUN, Y. P., CASAZZA, J. P., SOHN, D. H., VEECH, R. L. AND SONG, B. J.: Pretranslational activation of cytochrome P450IIE during ketosis induced by a high fat diet. Mol. Pharmacol. 41: 474-479, 1992.
58. ZERILLI, A., LUCAS, D., AMET, Y., BEAUGE, F., VOLANT, A., FLOCH, H. H., BERTHOU, F. AND MENEZ, J. F.: Cytochrome P-450 2E1 in rat liver, kidney, and lung microsomes after chronic administration of ethanol either orally or by inhalation. Alcohol Alcohol. 30: 357-365, 1995.